المؤلفون: M. Pavel, E. Baudin, A. Couvelard, E. Krenning, K. Öberg, T. Steinmüller, M. Anlauf, B. Wiedenmann, R. Salazar, B. C. Conference Anlauf M, Arnold R, Bartsch D, Baudin E, Baum R, Brandi ML, Cadiot G, Costa F, Caplin M, Couvelard A, de Herder W, Delle Fave G, Denecke T, Eriksson B, Gress T, Gross D, Grossman A, Jensen R, Kaltsas G, Kelestimur F, Kianmanesh R, Klöppel G, Klose KJ, Knigge U, Komminoth P, Kos Kudla B, Krenning E, Kwekkeboom D, Lopes JM, Niederle B, Nilsson O, Öberg K, O'Connor J, O'Toole D, Pape UF, Papotti M, Pascher A, Pavel M, Perren A, Plöckinger U, Rindi G, Ruszniewski P, Salazar R, Sasano H, Sauvanet A, Scoazec JY, Steinmüller T, Sundin A, Taal B, Tomassetti P, Van Cutsem E, Vullierme MP, Wiedenmann B., FALCONI , MASSIMO

المساهمون: M., Pavel, E., Baudin, A., Couvelard, E., Krenning, K., Öberg, T., Steinmüller, M., Anlauf, B., Wiedenmann, R., Salazar, B. C., Conference Anlauf M, Arnold, R, Bartsch, D, Baudin, E, Baum, R, Brandi, Ml, Cadiot, G, Costa, F, Caplin, M, Couvelard, A, de Herder, W, Delle Fave, G, Denecke, T, Eriksson, B, Falconi, Massimo, Gress, T, Gross, D, Grossman, A, Jensen, R, Kaltsas, G, Kelestimur, F, Kianmanesh, R, Klöppel, G, Klose, Kj, Knigge, U, Komminoth, P, Kos Kudla, B, Krenning, E, Kwekkeboom, D, Lopes, Jm, Niederle, B, Nilsson, O, Öberg, K, O'Connor, J, O'Toole, D, Pape, Uf, Papotti, M, Pascher, A, Pavel, M, Perren, A, Plöckinger, U, Rindi, G, Ruszniewski, P, Salazar, R, Sasano, H, Sauvanet, A, Scoazec, Jy, Steinmüller, T, Sundin, A, Taal, B, Tomassetti, P, Van Cutsem, E, Vullierme, Mp, Wiedenmann, B., Radiology & Nuclear Medicine

المصدر: Neuroendocrinology, 95(2), 157-176. Karger

مصطلحات موضوعية: medicine.medical_specialty, animal structures, Endocrinology, Diabetes and Metabolism, Intestinal Neoplasm, Neuroendocrine tumors, Biology, digestive system, Cellular and Molecular Neuroscience, Endocrinology, stomatognathic system, Internal medicine, Intestinal Neoplasms, medicine, Humans, Endocrine and Autonomic Systems, Liver Neoplasms, fungi, Midgut, Hindgut, Foregut, medicine.disease, Neuroendocrine Tumors, embryonic structures, Unknown primary, Neoplasms, Unknown Primary

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0c9bbd10d587c8ff3b39694f2b9b06dTest
https://doi.org/10.1159/000335597Test

المؤلفون: Philippe Ruszniewski, Tahir Shah, Ulrich Frank Pape, Aude Houchard, Marianne Pavel, C. Lombard-Bohas, Xuan-Mai Truong Thanh, Francesco Panzuto, Ivan Borbath, Jarosław B. Ćwikła, Jaume Capdevila

المساهمون: Institut Català de la Salut, [Pavel M] Department of Medicine 1, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany. [Ćwikła JB] University of Warmia and Mazury, Olsztyn, Poland, Diagnostic and Therapeutic Center – Gammed, Warsaw, Poland. [Lombard-Bohas C] Edouard-Herriot Hospital, HCL Cancer Institute, Lyon, France. [Borbath I] Cliniques Universitaires Saint-Luc, Brussels, Belgium. [Shah T] Queen Elizabeth Hospital Birmingham, Birmingham, UK. [Pape UF] Charité – Universitätsmedizin Berlin, Berlin, Germany. Asklepios Klinik St Georg, Asklepios Tumourzentrum Hamburg, Asklepios Medical School, Hamburg, Germany. [Capdevila J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Service de gastro-entérologie

المصدر: Scientia
European journal of cancer (Oxford, England : 1990), Vol. 157, no.157, p. 403-414 (2021)

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, lanreotide, neuroendocrine tumours, progression-free survival, receptors, somatostatin, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Phases of clinical research, Antineoplastic Agents, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Lanreotide, Peptides, Cyclic, Gastroenterology, Drug Administration Schedule, chemistry.chemical_compound, Neuroendocrine tumours, Quality of life, Internal medicine, Receptors, medicine, Humans, Prospective Studies, Progression-free survival, Adverse effect, Aged, neoplasias::neoplasias por tipo histológico::neoplasias de células germinales y embrionarias::tumores neuroectodérmicos::tumores neuroendocrinos [ENFERMEDADES], Dose-Response Relationship, Drug, business.industry, Midgut, Tumors neuroendocrins - Tractament, Middle Aged, Posologia, Progression-Free Survival, Pancreatic Neoplasms, Neuroendocrine Tumors, Regimen, Oncology, chemistry, Neoplasms::Neoplasms by Histologic Type::Neoplasms, Germ Cell and Embryonal::Neuroectodermal Tumors::Neuroendocrine Tumors [DISEASES], Cohort, Disease Progression, Quality of Life, Female, Somatostatin, business, Gels

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d78ade697d46998775c9b6ad82708dfTest
https://doi.org/10.1016/j.ejca.2021.06.056Test